Home - Products - Cell Cycle/DNA Damage - CDK - Cdc7-IN-7

Cdc7-IN-7

CAS No. 1402059-17-9

Cdc7-IN-7( —— )

Catalog No. M32832 CAS No. 1402059-17-9

Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	178	Get Quote
5MG	255	Get Quote
10MG	374	Get Quote
25MG	606	Get Quote
50MG	864	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Cdc7-IN-7
Note

Research use only, not for human use.
Brief Description

Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.
Description

Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

CDK
Recptor

CDK
Research Area

——
Indication

——

Chemical Information

CAS Number

1402059-17-9
Formula Weight

410.42
Molecular Formula

C21H22N4O5
Purity

>98% (HPLC)
Solubility

——
SMILES

C(OCC1CC1)(=O)C2=C(NN3CCOCC3)OC(=CC=4C=5C(NC4)=NC=CC5)C2=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CDK5-IN-3

CDK5-IN-3 is a selective and potent CDK5 inhibitor that inhibits CDK5/p25 and CDK2/CycA and can be used in the study of cancer.
Riviciclib

A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.
9-Isopropylolomoucin...

9-Isopropylolomoucine (N9-Isopropylolomoucine), a cell cycle protein-dependent kinase inhibitor, is a thiopurine.

Sign In Join Free